Filing Details

Accession Number:
0001209191-23-036395
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-06-12 17:25:40
Reporting Period:
2023-06-08
Accepted Time:
2023-06-12 17:25:40
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1819790 Tarsus Pharmaceuticals Inc. TARS () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1788542 Aziz Mottiwala C/O Tarsus Pharmaceuticals, Inc.
15440 Laguna Canyon Road, Suite 160
Irvine CA 92618
Chief Commercial Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2023-06-08 100 $20.00 48,086 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 26, 2022.